ArticleCell proliferation2020

IL2RG-deficient minipigs generated via CRISPR/Cas9 technology support the growth of human melanoma-derived tumours.

Jilong Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.